- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
UPDATED Apr 24, 2024
Companies with a Value score of at least 3, ordered by Value score
364 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DAL | US$59.75 | 0% | 0% | US$30.7b | US$72.34 | PE6.1x | E0.7% | 0.8% | Transportation | ||
BARC | UK£1.71 | 0% | 0% | UK£28.7b | UK£2.19 | PB0.4x | E9.4% | 4.2% | Banks | ||
CWC | €92.60 | 0% | 0% | €692.9m | €124.27 | PE11.6x | E3.3% | 2.6% | Commercial Services | ||
CONT | €144.60 | 0% | 0% | €12.6b | €190.80 | PE10.9x | E18.8% | 3.5% | Automobiles | ||
BA | US$350.00 | 0% | 0% | US$100.8b | US$487.84 | PS1.3x | E54.4% | 0% | Capital Goods | ||
VETN | CHF31.40 | 0.6% | -31.4% | CHF622.5m | CHF45.33 | PE9.8x | E12.0% | 3.2% | Materials | ||
ADEN | CHF31.26 | -0.3% | 4.7% | CHF5.2b | CHF38.64 | PE16.5x | E22.8% | 8.0% | Commercial Services | ||
BIIB | US$222.00 | 0% | 0% | US$29.4b | US$314.92 | PE25.2x | E17.9% | n/a | Pharmaceuticals & Biotech | ||
MOZN | CHF13.24 | -0.2% | -1.0% | CHF571.2m | CHF16.70 | PE11.5x | E5.8% | 3.7% | Retail | ||
ZEHN | CHF52.80 | -2.6% | -25.0% | CHF588.9m | CHF67.04 | PE13.9x | E6.0% | 2.5% | Capital Goods | ||
ASCN | CHF7.41 | -1.9% | -14.2% | CHF266.1m | CHF12.17 | PE15.3x | E12.9% | 4.0% | Healthcare | ||
BOSS | €80.00 | 0% | 0% | €3.5b | €110.98 | PE13.6x | E13.8% | 2.7% | Consumer Durables | ||
DBAN | €33.50 | 0% | 0% | €512.1m | €53.37 | PE8.8x | E25.0% | 3.6% | Diversified Financials | ||
JEN | €37.10 | 0% | 0% | €1.4b | €52.94 | PE19.4x | E16.0% | 1.4% | Tech | ||
ZEHNE | CHF54.60 | -1.3% | 5.6% | CHF603.2m | CHF80.77 | PE11.6x | E6.7% | 3.3% | Capital Goods | ||
BABA | US$160.00 | 0% | -2.4% | US$176.3b | US$236.12 | PE12.7x | E11.1% | 1.4% | Retail | ||
TEVA | US$7.85 | 0% | 0% | US$14.7b | US$9.49 | PB2x | E32.1% | 0% | Pharmaceuticals & Biotech | ||
4MGN | US$31.97 | 0% | n/a | US$8.5b | US$44.11 | PE13.1x | E7.8% | n/a | Media | ||
MO | US$47.20 | 0% | -2.1% | US$73.6b | US$51.29 | PE9.1x | E2.2% | 9.1% | Food, Beverage & Tobacco | ||
UBSGE | CHF19.44 | 0% | 0% | CHF80.3b | CHF21.27 | PE3.2x | E-33.6% | 2.6% | Diversified Financials | ||
SDZ | CHF30.61 | 6.7% | n/a | CHF13.2b | CHF35.21 | PE187.1x | E29.7% | 1.5% | Pharmaceuticals & Biotech | ||
NOVN | CHF89.12 | 5.4% | -2.4% | CHF181.8b | CHF98.84 | PE21.9x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
24409862 | US$160.00 | 0% | n/a | US$181.6b | US$224.88 | PE13.2x | E10.6% | 1.3% | Retail | ||
PBB | €12.34 | 0% | 0% | €618.6m | €14.66 | PE9.1x | E28.2% | 0% | Diversified Financials |